Home | Contact Us | Bookmark     About CLDF Centers of Educational Expertise

Hepatology Centers of Educational Expertise   Dr. Tong Myron Tong, MD is the Professor of Medicine for Clinical Hepatology and the Director of Asian Liver Center at the UCLA David Geffen School of Medicine. A world-leading hepatologist, Dr. Tong has specialized in liver-disease research and treatment for more than 25 years, with a distinguished record of service to the university and community. The first to link HBV infection with liver cancer, Dr. Tong is one of the leading clinical investigators on HBV and liver diseases in Asians in the U.S. and Asia. Dr. Tong's research efforts include anti-viral treatment of patients with hepatitis B and hepatitis C, and he is heavily involved in the treatment of patients with hepatocellular carcinoma at UCLA.  More     Ask the Expert Archive      Featured Webcasts     Physician Resources      My Publications More       Hepatitis B inactive carriers: clinical course and outcomes.     Complete tumor encapsulation on MRI: A potentially useful imaging biomarker for better survival in solitary large hepatocellular carcinoma     Chronic alcohol-induced hepatic insulin resistance and ER stress ameliorated by PPAR-d agonist treatment     MRI detection of intratumoral fat in hepatocellular carcinoma: potential biomarker for a more favorable prognosis       Disease Educational Content       Hepatic Encephalopathy Update: Reports From the 2013 Digestive Disease Week Annual Meeting   Educational eNewsletter       Hepatic Encephalopathy Update: Reports from the 2013 International Liver Conference   Educational eNewsletter       Hepatic Encephalopathy: A Review of Diagnostic Methods   Educational eNewsletter       2012 Update: Clinical Advances in the Management of Cirrhotics   Educational Audiocast       Hepatic Encephalopathy Update: Prophylactic Therapy to Prevent Hepatic Encephalopathy   Educational eNewsletter       Hepatic Encephalopathy Update: Reports from the 2012 International Liver Conference   Educational eNewsletter       2012 EASL HE Posters   Educational ePosters       The Multidimensional Burden of Hepatic Encephalopathy   Educational eNewsletter       Hepatic Encephalopathy Update: Reports From the American Association for the Study of Liver Diseases Annual Meeting, 2011   Educational eNewsletter       Hepatic Encephalopathy Update: Reports from Digestive Disease Week 2011   Educational eNewsletter       Moving Ahead: Advances in Hepatic Encephalopathy Awareness, Diagnosis, and Management   Educational eNewsletter       2011 EASL HE Posters   Educational ePosters       Hepatic Encephalopathy Update: Reports From the 2011 European Association for the Study of the Liver Conference   Educational eNewsletter       2011 Update on HCV   Educational Webcast         Institution Information Our mission is to deliver leading-edge patient care, research, and education. Our vision is to heal humankind, one patient at a time, by improving health, alleviating suffering and delivering acts of kindness.               Liver News - REUTERS     FDA panel backs drug for generalized lipodystrophy     12-11-2013           AbbVie says most in hepatitis C study show improvement     12-10-2013           CORRECTION: Technician sentenced to 39 years for spreading hepatitis     12-03-2013           Telaprevir effective for treating advanced hepatitis C     11-29-2013           View Complete News Library         Journal Abstracts     Influence of vitamin D-related gene polymorphisms (CYP27B and VDR) on the response to interferon/ribavirin therapy in chronic hepatitis C           Telaprevir-induced, but not pegylated interferon-associated, retinopathy as a noteworthy adverse effect during triple antiviral therapy in patients with chronic hepatitis C           Anti-TNF therapy in patients with HBV infection-analysis of 87 patients with inflammatory arthritis           Branched-chain amino acids in liver diseases           Treatment of hyperammonemia in liver failure           Absence of Viable HCC in the Native Liver Is an Independent Protective Factor of Tumor Recurrence After Liver Transplantation           View All Articles         Congress Calendar     January 13-14     7th PARIS HEPATITIS CONFERENCE Paris       January 24-25     30th ANNUAL MEETING OF THE GERMAN ASSOCIATION FOR THE STUDY OF THE LIVER TUBINGEN, Germany       February 4-7     STOCKHOLM LIVER WEEK 2013 Stockholm       February 8-11     CDDW: Canadian Digestive Diseases Week and Annual Canadian Association for the Study of the Liver (CASL) Winter Meeting Fairmont Royal York, Toronto, Ontario             View All Conventions

HBV Webcasts Slide Library Abstract Library   HE CME Dinner Meeting Slide Library Abstract Library   HCC Slide Library Abstract Library     HCV Slide Library Abstract Library         About CLDF Mission Statement Board of Trustees Board of Advisors CLDF Supporters   Other Resources Liver News Library Journal Abstracts Hep C Link to Care   Centers of Educational Expertise Regional Map Ask the Expert             The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals. © Copyright 2012 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only. Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.